Comparison Overview

GenomeWeb

VS

Roularta Advertising

GenomeWeb

One Battery Park Plaza, New York, 10004, US
Last Update: 2025-11-21
View Profile
Between 750 and 799
https://www.genomeweb.com

GenomeWeb is an independent online news organization based in New York. Since 1997, GenomeWeb has served the global community of scientists, technology professionals, and executives who use and develop the latest advanced tools in molecular biology research and molecular diagnostics. GenomeWeb’s editorial mission is to cover the scientific and economic ecosystem spurred by the advent of high-throughput genome sequencing. We operate the largest online newsroom focused on advanced molecular research tools in order to provide our readers with exclusive news and in-depth analysis of this rapidly evolving market. GenomeWeb users can be found in major scientific organizations around the world, including biopharmaceutical companies, research universities, biomedical institutes, clinical labs, and government laboratories. Our advertisers include leading suppliers of research tools, analytical instruments, information technology, and molecular diagnostics. GenomeWeb is a business unit of Crain Communications.

NAICS: 511
NAICS Definition: Publishing Industries (except Internet)
Employees: 37
Subsidiaries: 2
12-month incidents
0
Known data breaches
0
Attack type number
0
View Profile

Roularta Advertising

Raketstraat 50, None, Evere, None, BE, 1130
Last Update: 2025-11-26
Between 750 and 799
http://www.roularta-advertising.be

Roularta Advertising, the national sales house of Roularta Media Group, excels in delivering cross-media advertising solutions across online, print, and television platforms. Our expertise allows us to connect advertisers with the right audiences, using tailored messaging to maximize impact. As the publisher of leading national magazines such as Knack/Le Vif, Trends/Trends Tendances, Flair, Libelle/Femmes d’Aujourd’hui, Plus Magazine, Data News, etc. we cover a diverse range of topics including news, politics, business, lifestyle, women, food, and health. Our media brands, including Belgium's largest free weekly, De Zondag, and the largest paid magazine, Libelle, reach a record number of readers, as confirmed by CIM figures from October 2023. Roularta Advertising is the go-to partner for national advertising campaigns, offering both classic and native formats in print and online to effectively reach both specific segments and the broader public. Let us help you tell your story and achieve the impact you seek. Storytelling is our talent; what's yours? Visit us at www.roularta-advertising.be.

NAICS: 511
NAICS Definition: Publishing Industries (except Internet)
Employees: 19
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/genomeweb-llc.jpeg
GenomeWeb
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/roularta-advertising.jpeg
Roularta Advertising
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
GenomeWeb
100%
Compliance Rate
0/4 Standards Verified
Roularta Advertising
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Book and Periodical Publishing Industry Average (This Year)

No incidents recorded for GenomeWeb in 2025.

Incidents vs Book and Periodical Publishing Industry Average (This Year)

No incidents recorded for Roularta Advertising in 2025.

Incident History — GenomeWeb (X = Date, Y = Severity)

GenomeWeb cyber incidents detection timeline including parent company and subsidiaries

Incident History — Roularta Advertising (X = Date, Y = Severity)

Roularta Advertising cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/genomeweb-llc.jpeg
GenomeWeb
Incidents

No Incident

https://images.rankiteo.com/companyimages/roularta-advertising.jpeg
Roularta Advertising
Incidents

No Incident

FAQ

GenomeWeb company demonstrates a stronger AI Cybersecurity Score compared to Roularta Advertising company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Historically, Roularta Advertising company has disclosed a higher number of cyber incidents compared to GenomeWeb company.

In the current year, Roularta Advertising company and GenomeWeb company have not reported any cyber incidents.

Neither Roularta Advertising company nor GenomeWeb company has reported experiencing a ransomware attack publicly.

Neither Roularta Advertising company nor GenomeWeb company has reported experiencing a data breach publicly.

Neither Roularta Advertising company nor GenomeWeb company has reported experiencing targeted cyberattacks publicly.

Neither GenomeWeb company nor Roularta Advertising company has reported experiencing or disclosing vulnerabilities publicly.

Neither GenomeWeb nor Roularta Advertising holds any compliance certifications.

Neither company holds any compliance certifications.

GenomeWeb company has more subsidiaries worldwide compared to Roularta Advertising company.

GenomeWeb company employs more people globally than Roularta Advertising company, reflecting its scale as a Book and Periodical Publishing.

Neither GenomeWeb nor Roularta Advertising holds SOC 2 Type 1 certification.

Neither GenomeWeb nor Roularta Advertising holds SOC 2 Type 2 certification.

Neither GenomeWeb nor Roularta Advertising holds ISO 27001 certification.

Neither GenomeWeb nor Roularta Advertising holds PCI DSS certification.

Neither GenomeWeb nor Roularta Advertising holds HIPAA certification.

Neither GenomeWeb nor Roularta Advertising holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

ThingsBoard in versions prior to v4.2.1 allows an authenticated user to upload malicious SVG images via the "Image Gallery", leading to a Stored Cross-Site Scripting (XSS) vulnerability. The exploit can be triggered when any user accesses the public API endpoint of the malicious SVG images, or if the malicious images are embedded in an `iframe` element, during a widget creation, deployed to any page of the platform (e.g., dashboards), and accessed during normal operations. The vulnerability resides in the `ImageController`, which fails to restrict the execution of JavaScript code when an image is loaded by the user's browser. This vulnerability can lead to the execution of malicious code in the context of other users' sessions, potentially compromising their accounts and allowing unauthorized actions.

Published
Date
2025-11-27
Updated
Date
2025-11-27
Risk Information
cvss4
Base: 6.2
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:N/VA:N/SC:H/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

Mattermost versions 11.0.x <= 11.0.2, 10.12.x <= 10.12.1, 10.11.x <= 10.11.4, 10.5.x <= 10.5.12 fail to to verify that the token used during the code exchange originates from the same authentication flow, which allows an authenticated user to perform account takeover via a specially crafted email address used when switching authentication methods and sending a request to the /users/login/sso/code-exchange endpoint. The vulnerability requires ExperimentalEnableAuthenticationTransfer to be enabled (default: enabled) and RequireEmailVerification to be disabled (default: disabled).

Published
Date
2025-11-27
Updated
Date
2025-11-27
Risk Information
cvss3
Base: 9.9
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
References
Description

Mattermost versions 11.0.x <= 11.0.2, 10.12.x <= 10.12.1, 10.11.x <= 10.11.4, 10.5.x <= 10.5.12 fail to sanitize team email addresses to be visible only to Team Admins, which allows any authenticated user to view team email addresses via the GET /api/v4/channels/{channel_id}/common_teams endpoint

Published
Date
2025-11-27
Updated
Date
2025-11-27
Risk Information
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
References
Description

Exposure of email service credentials to users without administrative rights in Devolutions Server.This issue affects Devolutions Server: before 2025.2.21, before 2025.3.9.

Published
Date
2025-11-27
Updated
Date
2025-11-27
References
Description

Exposure of credentials in unintended requests in Devolutions Server.This issue affects Server: through 2025.2.20, through 2025.3.8.

Published
Date
2025-11-27
Updated
Date
2025-11-27
References